Renal Cell - Targeted Therapy First Line
Published: Fri Oct 7, 2011 Updated:Fri Oct 21, 2011
-
Sarcomatoid-variant Renal Cell Carcinoma: Treatment Outcome and Survival in Advanced Disease
AM Molina et al. October 2011 - Volume 34 - Issue 5 - p 454–459 doi: 10.1097/COC.0b013e3181f47aa
-
Critical appraisal of pazopanib as treatment for patients with advanced metastatic renal cell carcinoma
RM Bukowski et al, Aug, 2011; DOI: http://dx.doi.org/10.2147/CMAR.S15557
-
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
CN Sternberg et al, JCO. Feb 20 2010; 28(6):1061-68 Review by Dr Wood
-
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
ME Gore et al, Lancet Oncol. Aug 2009; 10(8):757-763
-
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
RJ Motzer et al, JCO. Aug 1 2009; 27(22):3584-90 Article Review by Dr Heng
-
Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
B Escudier et al, JCO. Jul 10 2009; 27(20):3312-18
-
Quality of Life in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib or Interferon Alfa: Results From a Phase III Randomized Trial
D Cella et al, JCO. Aug 1 2008; 26(22):3763-69 Article Review by Dr Wood
-
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomized, double-blind phase III trial
B Escudier et al, Lancet. Dec 22 2007; 370:2103-11 Article Review by Drs L Wood & D Heng
-
Temsirolimus, Interferon-α, or Both for Advanced Renal-Cell Carcinoma
G Hudes et al, NEJM. May 31 2007; 356(22):2271-81 Article Review by Dr Lori Wood
-
Sunitinib versus Interferon-α in Metastatic Renal-Cell Carcinoma
RJ Motzer et al, NEJM. Jan 11 2007; 356(2):115-24
-
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
B Escudier et al, NEJM. Jan 11 2007; 356(2):125-34
-
Targeted Therapy for Metastatic Renal Cell Carcinoma
RJ Motzer et al, JCO. Dec 10 2006; 24(35):5601-8
